Gheith, Osama A <br/><br/>
Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.  [electronic resource] 

 -  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation  Apr 2011 
 - 121-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2146-8427 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Basiliximab<br/>Comorbidity<br/>Contraindications<br/>Cost-Benefit Analysis<br/>Diabetes Mellitus--economics<br/>Female<br/>Graft Rejection--epidemiology<br/>Humans<br/>Hyperlipidemias--economics<br/>Hypertension--economics<br/>Immunosuppression Therapy--economics<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Kidney Transplantation--immunology<br/>Living Donors<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Prospective Studies<br/>Recombinant Fusion Proteins--therapeutic use<br/>Steroids--adverse effects<br/>Tacrolimus--therapeutic use<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult